WHO's Global Benchmarking Tool (GBT) assesses the maturity of national regulatory authorities for medicines and vaccines, helping countries strengthen regulatory systems to ensure product quality, safety, and efficacy, and facilitate access to _____ medical products.
- expensive
- imported
- quality-assured
- experimental
Answer: quality-assured
Regulatory strengthening via GBT enables countries to efficiently evaluate, authorize, and monitor medical products. This accelerates access to vaccines, treatments, and diagnostics, particularly during emergencies, while building sustainable national capacity for health security.